9 results
10-K
2020 FY
PSTX
Poseida Therapeutics Inc
11 Mar 21
Annual report
4:11pm
to innovate and develop our platform technologies. Our platform technologies are highly differentiated with the ability to create many product candidates
424B4
PSTX
Poseida Therapeutics Inc
10 Jul 20
Prospectus supplement with pricing info
4:55pm
partnerships and structures to create value and continue to innovate and develop our platform technologies. Our platform technologies are highly … to create value and continue to innovate and develop our platform technologies. Our platform technologies are highly differentiated with the ability
DRS/A
novssc o3i
27 May 20
Draft registration statement (amended)
12:00am
DRS
fmt1ch rdln1vh9k
17 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next